Blog Posts

Flavio G Rocha: Dose density in neoadjuvant treatment for PDAC

Flavio Rocha/X

Feb 12, 2025, 17:33

Flavio G Rocha: Dose density in neoadjuvant treatment for PDAC

Flavio G Rocha, Hedinger Chair of Surgical Oncology and Physician-in-Chief OHSU Knight Cancer Institute, shared on X about recent paper by Sameer Patel et al., titled “Chemotherapy dose density is prognostic for overall survival in patients with resectable pancreas cancer: A landmark analysis of SWOG 1505” published on ACS Journals.

Authors: Sameer H. Patel, Sarah Colby, Davendra Sohal, Katherine A. Guthrie, Lisa A. Kachnic, E. Gabriela Chiorean, Andrew M. Lowy, Flavio G. Rocha, Howard S. Hochster, Philip A. Philip, Syed A. Ahmad

“Dose density in neoadjuvant treatment for PDAC

A landmark analysis of SWOG S1505
DD >85% pre or DD >70% periop lead to OS benefit

Kudos to investigators and lead author Dr. Sameer Patel.“

Andrew M. Lowy cancer Davendra Sohal E. Gabriela Chiorean Flavio G. Rocha Howard S Hochster Katherine A. Guthrie Lisa A. Kachnic OncoDaily Oncology Philip A. Philip Sameer H. Patel Sarah Colby Syed A. Ahmad

Vinay Prasad Rejoins FDA Days After Exit

New Paper Alert: Safety and Outcomes of T-DXd Retreatment After Grade 1 ILD Recovery

FDA Accepts NDA for Vepdegestrant in ESR1-Mutant ER+/HER2- Advanced Breast Cancer

Hubert Caron Retires from Roche-Genentech

Tyler Seibert: 10-year Results of FLAME Trial is Out Now